Cargando…
An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development
Classical type 1 dendritic cells (cDC1s) are required for anti-viral and anti-tumor immunity, which necessitates an understanding of their development. Development of the cDC1 progenitor requires an E protein–dependent enhancer located 41 kilobases downstream of the transcription start site of the t...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707889/ https://www.ncbi.nlm.nih.gov/pubmed/31406377 http://dx.doi.org/10.1038/s41590-019-0449-3 |
_version_ | 1783445924290232320 |
---|---|
author | Bagadia, Prachi Huang, Xiao Liu, Tiantian Durai, Vivek Grajales-Reyes, Gary E. Nitschke, Maximilian Modrusan, Zora Granja, Jeffrey M. Satpathy, Ansuman T. Briseño, Carlos G. Gargaro, Marco Iwata, Arifumi Kim, Sunkyung Chang, Howard Y. Shaw, Andrey S. Murphy, Theresa L. Murphy, Kenneth M. |
author_facet | Bagadia, Prachi Huang, Xiao Liu, Tiantian Durai, Vivek Grajales-Reyes, Gary E. Nitschke, Maximilian Modrusan, Zora Granja, Jeffrey M. Satpathy, Ansuman T. Briseño, Carlos G. Gargaro, Marco Iwata, Arifumi Kim, Sunkyung Chang, Howard Y. Shaw, Andrey S. Murphy, Theresa L. Murphy, Kenneth M. |
author_sort | Bagadia, Prachi |
collection | PubMed |
description | Classical type 1 dendritic cells (cDC1s) are required for anti-viral and anti-tumor immunity, which necessitates an understanding of their development. Development of the cDC1 progenitor requires an E protein–dependent enhancer located 41 kilobases downstream of the transcription start site of the transcription factor IRF8 (+41 kb Irf8 enhancer) but its maturation instead requires the BATF3-dependent +32 kb Irf8 enhancer. To understand this switch, we performed single-cell RNA sequencing of the common dendritic cell progenitor (CDP) and identified a cluster of cells that expressed transcription factors that influence cDC1 development, such as Nfil3, Id2, and Zeb2. Genetic epistasis among these factors revealed that Nfil3 expression is required for the transition from Zeb2(hi) and Id2(lo) CDPs to Zeb2(lo) and Id2(hi) CDPs, which represent the earliest committed cDC1 progenitors. This genetic circuit blocks E protein activity to exclude plasmacytoid DC potential and explains the switch in Irf8 enhancer usage during cDC1 development. |
format | Online Article Text |
id | pubmed-6707889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
record_format | MEDLINE/PubMed |
spelling | pubmed-67078892020-02-12 An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development Bagadia, Prachi Huang, Xiao Liu, Tiantian Durai, Vivek Grajales-Reyes, Gary E. Nitschke, Maximilian Modrusan, Zora Granja, Jeffrey M. Satpathy, Ansuman T. Briseño, Carlos G. Gargaro, Marco Iwata, Arifumi Kim, Sunkyung Chang, Howard Y. Shaw, Andrey S. Murphy, Theresa L. Murphy, Kenneth M. Nat Immunol Article Classical type 1 dendritic cells (cDC1s) are required for anti-viral and anti-tumor immunity, which necessitates an understanding of their development. Development of the cDC1 progenitor requires an E protein–dependent enhancer located 41 kilobases downstream of the transcription start site of the transcription factor IRF8 (+41 kb Irf8 enhancer) but its maturation instead requires the BATF3-dependent +32 kb Irf8 enhancer. To understand this switch, we performed single-cell RNA sequencing of the common dendritic cell progenitor (CDP) and identified a cluster of cells that expressed transcription factors that influence cDC1 development, such as Nfil3, Id2, and Zeb2. Genetic epistasis among these factors revealed that Nfil3 expression is required for the transition from Zeb2(hi) and Id2(lo) CDPs to Zeb2(lo) and Id2(hi) CDPs, which represent the earliest committed cDC1 progenitors. This genetic circuit blocks E protein activity to exclude plasmacytoid DC potential and explains the switch in Irf8 enhancer usage during cDC1 development. 2019-08-12 2019-09 /pmc/articles/PMC6707889/ /pubmed/31406377 http://dx.doi.org/10.1038/s41590-019-0449-3 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Bagadia, Prachi Huang, Xiao Liu, Tiantian Durai, Vivek Grajales-Reyes, Gary E. Nitschke, Maximilian Modrusan, Zora Granja, Jeffrey M. Satpathy, Ansuman T. Briseño, Carlos G. Gargaro, Marco Iwata, Arifumi Kim, Sunkyung Chang, Howard Y. Shaw, Andrey S. Murphy, Theresa L. Murphy, Kenneth M. An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development |
title | An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development |
title_full | An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development |
title_fullStr | An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development |
title_full_unstemmed | An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development |
title_short | An Nfil3–Zeb2–Id2 pathway imposes Irf8 enhancer switching during cDC1 development |
title_sort | nfil3–zeb2–id2 pathway imposes irf8 enhancer switching during cdc1 development |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707889/ https://www.ncbi.nlm.nih.gov/pubmed/31406377 http://dx.doi.org/10.1038/s41590-019-0449-3 |
work_keys_str_mv | AT bagadiaprachi annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT huangxiao annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT liutiantian annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT duraivivek annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT grajalesreyesgarye annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT nitschkemaximilian annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT modrusanzora annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT granjajeffreym annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT satpathyansumant annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT brisenocarlosg annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT gargaromarco annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT iwataarifumi annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT kimsunkyung annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT changhowardy annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT shawandreys annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT murphytheresal annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT murphykennethm annfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT bagadiaprachi nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT huangxiao nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT liutiantian nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT duraivivek nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT grajalesreyesgarye nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT nitschkemaximilian nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT modrusanzora nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT granjajeffreym nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT satpathyansumant nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT brisenocarlosg nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT gargaromarco nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT iwataarifumi nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT kimsunkyung nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT changhowardy nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT shawandreys nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT murphytheresal nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development AT murphykennethm nfil3zeb2id2pathwayimposesirf8enhancerswitchingduringcdc1development |